{"id":"NCT03620981","sponsor":"Otsuka Pharmaceutical Co., Ltd.","briefTitle":"Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type","officialTitle":"A Phase 2/3 Multicenter, Placebo-controlled, Randomized, Double-blind, Parallel-group Comparison Trial to Evaluate the Efficacy and Safety of Brexpiprazole (OPC-34712) in the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2018-08-20","primaryCompletion":"2023-04-21","completion":"2023-05-15","firstPosted":"2018-08-08","resultsPosted":"2024-11-14","lastUpdate":"2024-11-14"},"enrollment":410,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Agitation Associated With Dementia of the Alzheimer's Type"],"interventions":[{"type":"DRUG","name":"Brexpiprazole","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Brexpiprazole, 1mg/day","type":"EXPERIMENTAL"},{"label":"Brexpiprazole, 2mg/day","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate the superiority of brexpiprazole 1 mg or 2 mg over placebo after a 10-week treatment regimen for agitation associated with dementia of the Alzheimer's type in patients who require medication, and to investigate the safety of brexpiprazole and identify the optimum dose.","primaryOutcome":{"measure":"Change From Baseline in Cohen-Manfield Agitation Inventory(CMAI) Score at 10 Weeks After Dosing.","timeFrame":"Baseline and 10 weeks first dose, on average 10 weeks","effectByArm":[{"arm":"Brexpiprazole 1 mg","deltaMin":-11.7,"sd":1.2},{"arm":"Brexpiprazole 2 mg","deltaMin":-15.2,"sd":1.05},{"arm":"Placebo","deltaMin":-8,"sd":1.03}],"pValues":[{"comp":"OG001 vs OG002","p":"< 0.0001"},{"comp":"OG000 vs OG002","p":"0.0175"}]},"eligibility":{"minAge":"55 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":["40717666"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":112},"commonTop":["Insomnia","Contusion","Somnolence","Fall","Pyrexia"]}}